Caseware UK (AP4) 2023.0.135 2023.0.135 2024-08-312024-08-312025-05-19Development of technology in the healthcare sectorfalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.22023-08-22falsetruetrue 15088749 2023-08-21 15088749 2023-08-22 2024-08-31 15088749 2022-08-22 2023-08-21 15088749 2024-08-31 15088749 c:Director1 2023-08-22 2024-08-31 15088749 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-08-31 15088749 d:CurrentFinancialInstruments 2024-08-31 15088749 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 15088749 d:ShareCapital 2023-08-22 2024-08-31 15088749 d:ShareCapital 2024-08-31 15088749 c:FRS102 2023-08-22 2024-08-31 15088749 c:AuditExempt-NoAccountantsReport 2023-08-22 2024-08-31 15088749 c:FullAccounts 2023-08-22 2024-08-31 15088749 c:PrivateLimitedCompanyLtd 2023-08-22 2024-08-31 15088749 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:ExternallyAcquiredIntangibleAssets 2023-08-22 2024-08-31 15088749 e:PoundSterling 2023-08-22 2024-08-31 iso4217:GBP xbrli:pure
Registered number: 15088749











HEALTHFINDER TECH LIMITED
UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE PERIOD ENDED 31 AUGUST 2024



















FLETCHER & PARTNERS
CHARTERED ACCOUNTANTS
SALISBURY

 
HEALTHFINDER TECH LIMITED
REGISTERED NUMBER:15088749

BALANCE SHEET
AS AT 31 AUGUST 2024

2024
Note
£

Fixed assets
  

Intangible assets
 4 
60,429

  
60,429

Current assets
  

Cash at bank and in hand
 5 
12,191

  
12,191

Creditors: amounts falling due within one year
 6 
(72,520)

Net current (liabilities)/assets
  
 
 
(60,329)

Total assets less current liabilities
  
100

  

Net assets
  
100


Capital and reserves
  

Called up share capital 
  
100

  
100


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 19 May 2025.




Mr Michael Arnold
Director

The notes on pages 3 to 5 form part of these financial statements.
Page 1

 
HEALTHFINDER TECH LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 AUGUST 2024


Called up share capital
Total equity

£
£


Other comprehensive income for the period
-
-


Total comprehensive income for the period
-
-


Contributions by and distributions to owners

Shares issued during the period
100
100


Total transactions with owners
100
100


At 31 August 2024
100
100

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
HEALTHFINDER TECH LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 AUGUST 2024

1.


General information

Healthfinder Tech Limited is a private company limited by shares incorporated in England and Wales number 15088749 registered office First Floor, Highfield House, Bartons Road, Fordingbridge, Hampshire SP6 1JD.  Its principal activity is the development and application of software in the health care sector. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.3

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 3

 
HEALTHFINDER TECH LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 AUGUST 2024

3.


Employees

The average monthly number of employees, including the directors, during the period was as follows:


     Period ended
       31 August
        2024
            No.






Directors
2


4.


Intangible assets



Developm't expenditure

£



Cost


Additions
60,429



At 31 August 2024

60,429






Net book value



At 31 August 2024
60,429




5.


Cash and cash equivalents

2024
£

Cash at bank and in hand
12,191

12,191



6.


Creditors: Amounts falling due within one year

2024
£

Other taxation and social security
20

Other creditors
72,500

72,520


Page 4

 
HEALTHFINDER TECH LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 AUGUST 2024

7.


Related party transactions

''Other creditors' comprises a loan of £72,500 from the director Mr M Arnold which is unsecured, interest-free and repayable on demand.

Page 5